EcoDrugPlus

Protein Kinase C Gamma

Ensembl ID : ENSDORG00000003929
Gene Symbol: PRKCG
4 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSDORG00000014568
Gene Symbol: PRKCI
3 Cross references
226 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSDORG00000015923
Gene Symbol: PRKCQ
4 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSDORG00000015442
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSDORG00000000354
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSDORG00000009493
Gene Symbol: PRKD3
3 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSDORG00000014936
Gene Symbol: PRKACA
4 Cross references
288 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSDORG00000004341
Gene Symbol: PRKACB
4 Cross references
304 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSDORG00000004417
Gene Symbol: PRKDC
3 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSDORG00000002043
Gene Symbol: PPP3CA
4 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSDORG00000014660
Gene Symbol: PTK2
3 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSDORG00000010200
Gene Symbol: PTK2B
4 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).